Russell Investments Group’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.7K | Sell |
3,759
-181
| -5% | -$610 | ﹤0.01% | 3282 |
|
2025
Q1 | $15.2K | Buy |
3,940
+881
| +29% | +$3.4K | ﹤0.01% | 3159 |
|
2024
Q4 | $18.9K | Sell |
3,059
-1,433
| -32% | -$8.84K | ﹤0.01% | 3021 |
|
2024
Q3 | $24.2K | Sell |
4,492
-3,752
| -46% | -$20.2K | ﹤0.01% | 2918 |
|
2024
Q2 | $27.6K | Buy |
8,244
+3,933
| +91% | +$13.2K | ﹤0.01% | 2885 |
|
2024
Q1 | $17.4K | Buy |
4,311
+2,447
| +131% | +$9.86K | ﹤0.01% | 2789 |
|
2023
Q4 | $4.94K | Buy |
1,864
+1,251
| +204% | +$3.32K | ﹤0.01% | 2908 |
|
2023
Q3 | $1.45K | Sell |
613
-781
| -56% | -$1.84K | ﹤0.01% | 3300 |
|
2023
Q2 | $8.78K | Buy |
1,394
+402
| +41% | +$2.53K | ﹤0.01% | 2989 |
|
2023
Q1 | $5.72K | Hold |
992
| – | – | ﹤0.01% | 2937 |
|
2022
Q4 | $10.2K | Hold |
992
| – | – | ﹤0.01% | 2844 |
|
2022
Q3 | $16K | Sell |
992
-1,352
| -58% | -$21.8K | ﹤0.01% | 2827 |
|
2022
Q2 | $32K | Buy |
+2,344
| New | +$32K | ﹤0.01% | 2758 |
|